Delisting riskPopularity #3,749
LUCD · NASDAQ · Medical - Devices

Lucid Diagnostics (LUCD)

Commercializes EsoGuard testing on esophageal cells collected with EsoCheck.

$0.8652
After-hours close−0.02 (−2.10%)
At close$0.8838(+4.58%)